These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6102789)

  • 1. Drug and psychosocial therapy in schizophrenia: current status and research needs.
    Goldberg SC
    Schizophr Bull; 1980; 6(1):117-21. PubMed ID: 6102789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptics and psychosocial treatments: a discussion.
    Schooler NR
    Schizophr Bull; 1980; 6(1):131-4. PubMed ID: 6102790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial treatment: individual, group, family, and community support approaches.
    Mosher LR; Keith SJ
    Schizophr Bull; 1980; 6(1):10-41. PubMed ID: 6102787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current outcome in schizophrenia: women vs men.
    Seeman MV
    Acta Psychiatr Scand; 1986 Jun; 73(6):609-17. PubMed ID: 2875610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and limitations of neuroleptics--and other forms of treatment--in schizophrenia.
    Marder SR; May PR
    Am J Psychother; 1986 Jul; 40(3):357-69. PubMed ID: 2876653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic schizophrenic outpatients.
    Torrey EF
    Psychiatr Clin North Am; 1986 Mar; 9(1):143-51. PubMed ID: 2870477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of ECT in the treatment of schizophrenia.
    Salzman C
    Am J Psychiatry; 1980 Sep; 137(9):1032-41. PubMed ID: 6107048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study.
    Falloon IR; Boyd JL; McGill CW; Williamson M; Razani J; Moss HB; Gilderman AM; Simpson GM
    Arch Gen Psychiatry; 1985 Sep; 42(9):887-96. PubMed ID: 2864032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia in 2 patients treated with ziprasidone.
    Ananth J; Burgoyne KS; Niz D; Smith M
    J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.